000661.SZ · 长春高新
China A-shares · RS rating 44 · As of 2026-10-14
| Price | 70.34 CNY |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 60 / 67 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 11 / 21 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +14.2% |
| Distance from 52-week high | +48.4% |
| Market cap (USD) | $4.4B |